Brain tumour clinical trial title
Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumours (Study ID: 34954)
Brain tumour type
Paediatric,
Glioma,
Website
www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCI-2017-02402&r=1
Description:
A Phase 2 study that will assess the efficacy, safety and tolerability of pomalidomide in children and young adults aged 1 to < 21 years with recurrent or progressive primary brain tumors. The study will consist of 4 parallel groups, one for each of the following primary brain tumor types: high-grade glioma, medulloblastoma, ependymoma and DIPG. A Simon's Optimal two-stage study design will be applied to each group.
Date added:
11th January 2019
Open/Closed:
Open
Trial ends:
March 2023
Provider
Leeds General Infirmary
Contact details